Table of Content

1 Study Coverage
1.1 Anti-Vascular Endothelial Growth Factor Therapeutic Product Introduction
1.2 Market by Type
1.2.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Aflibercept (Eylea)
1.2.3 Ranibizumab (Lucentis)
1.2.4 Brolucizumab (Beovu)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Macular Edema
1.3.3 Diabetic Retinopathy
1.3.4 Retinal Vein Occlusion
1.3.5 Age-related Macular Degeneration
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Estimates and Forecasts 2018-2029
2.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region
2.2.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region (2018-2024)
2.2.3 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region (2024-2029)
2.2.4 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Region (2018-2029)
2.3 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Estimates and Forecasts 2018-2029
2.4 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region
2.4.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region (2018-2024)
2.4.3 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region (2024-2029)
2.4.4 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Manufacturers
3.1.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Manufacturers (2018-2024)
3.1.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Vascular Endothelial Growth Factor Therapeutic in 2022
3.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Manufacturers
3.2.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Manufacturers (2018-2024)
3.2.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Anti-Vascular Endothelial Growth Factor Therapeutic Revenue in 2022
3.3 Global Key Players of Anti-Vascular Endothelial Growth Factor Therapeutic, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Anti-Vascular Endothelial Growth Factor Therapeutic, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Anti-Vascular Endothelial Growth Factor Therapeutic, Product Offered and Application
3.8 Global Key Manufacturers of Anti-Vascular Endothelial Growth Factor Therapeutic, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type
4.1.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Historical Sales by Type (2018-2024)
4.1.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Forecasted Sales by Type (2024-2029)
4.1.3 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type (2018-2029)
4.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type
4.2.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Historical Revenue by Type (2018-2024)
4.2.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Forecasted Revenue by Type (2024-2029)
4.2.3 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Type (2018-2029)
4.3 Global Anti-Vascular Endothelial Growth Factor Therapeutic Price by Type
4.3.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Price by Type (2018-2024)
4.3.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application
5.1.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Historical Sales by Application (2018-2024)
5.1.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Forecasted Sales by Application (2024-2029)
5.1.3 Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Application (2018-2029)
5.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application
5.2.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Historical Revenue by Application (2018-2024)
5.2.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Forecasted Revenue by Application (2024-2029)
5.2.3 Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Application (2018-2029)
5.3 Global Anti-Vascular Endothelial Growth Factor Therapeutic Price by Application
5.3.1 Global Anti-Vascular Endothelial Growth Factor Therapeutic Price by Application (2018-2024)
5.3.2 Global Anti-Vascular Endothelial Growth Factor Therapeutic Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Market Size by Type
6.1.1 US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2018-2029)
6.1.2 US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2018-2029)
6.2 US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Market Size by Application
6.2.1 US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2018-2029)
6.2.2 US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2018-2029)
6.3 US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Market Size by Country
6.3.1 US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2018-2029)
6.3.3 US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Anti-Vascular Endothelial Growth Factor Therapeutic Market Size by Type
7.1.1 Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2018-2029)
7.1.2 Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2018-2029)
7.2 Europe Anti-Vascular Endothelial Growth Factor Therapeutic Market Size by Application
7.2.1 Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2018-2029)
7.2.2 Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2018-2029)
7.3 Europe Anti-Vascular Endothelial Growth Factor Therapeutic Market Size by Country
7.3.1 Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2018-2029)
7.3.3 Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Anti-Vascular Endothelial Growth Factor Therapeutic Market Size
8.1.1 China Anti-Vascular Endothelial Growth Factor Therapeutic Sales (2018-2029)
8.1.2 China Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029)
8.2 China Anti-Vascular Endothelial Growth Factor Therapeutic Market Size by Application
8.2.1 China Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2018-2029)
8.2.2 China Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Anti-Vascular Endothelial Growth Factor Therapeutic Market Size by Type
9.1.1 Asia Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2018-2029)
9.1.2 Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2018-2029)
9.2 Asia Anti-Vascular Endothelial Growth Factor Therapeutic Market Size by Application
9.2.1 Asia Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2018-2029)
9.2.2 Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2018-2029)
9.3 Asia Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region
9.3.1 Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region (2018-2029)
9.3.3 Asia Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Market Size by Type
10.1.1 Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Market Size by Application
10.2.1 Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country
10.3.1 Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Regeneron Pharmaceuticals
11.1.1 Regeneron Pharmaceuticals Company Information
11.1.2 Regeneron Pharmaceuticals Overview
11.1.3 Regeneron Pharmaceuticals Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Regeneron Pharmaceuticals Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Regeneron Pharmaceuticals Recent Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Overview
11.2.3 Bayer Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Bayer Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Overview
11.3.3 Novartis Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novartis Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Overview
11.4.3 Roche Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Roche Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Roche Recent Developments
11.5 Biogen
11.5.1 Biogen Company Information
11.5.2 Biogen Overview
11.5.3 Biogen Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Biogen Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biogen Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Pfizer Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Coherus BioSciences
11.7.1 Coherus BioSciences Company Information
11.7.2 Coherus BioSciences Overview
11.7.3 Coherus BioSciences Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Coherus BioSciences Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Coherus BioSciences Recent Developments
11.8 Amgen
11.8.1 Amgen Company Information
11.8.2 Amgen Overview
11.8.3 Amgen Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Amgen Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Amgen Recent Developments
11.9 Bausch Health Companies
11.9.1 Bausch Health Companies Company Information
11.9.2 Bausch Health Companies Overview
11.9.3 Bausch Health Companies Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Bausch Health Companies Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bausch Health Companies Recent Developments
11.10 Viatris
11.10.1 Viatris Company Information
11.10.2 Viatris Overview
11.10.3 Viatris Anti-Vascular Endothelial Growth Factor Therapeutic Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Viatris Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Viatris Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-Vascular Endothelial Growth Factor Therapeutic Industry Chain Analysis
12.2 Anti-Vascular Endothelial Growth Factor Therapeutic Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-Vascular Endothelial Growth Factor Therapeutic Production Mode & Process
12.4 Anti-Vascular Endothelial Growth Factor Therapeutic Sales and Marketing
12.4.1 Anti-Vascular Endothelial Growth Factor Therapeutic Sales Channels
12.4.2 Anti-Vascular Endothelial Growth Factor Therapeutic Distributors
12.5 Anti-Vascular Endothelial Growth Factor Therapeutic Customers
13 Market Dynamics
13.1 Anti-Vascular Endothelial Growth Factor Therapeutic Industry Trends
13.2 Anti-Vascular Endothelial Growth Factor Therapeutic Market Drivers
13.3 Anti-Vascular Endothelial Growth Factor Therapeutic Market Challenges
13.4 Anti-Vascular Endothelial Growth Factor Therapeutic Market Restraints
14 Key Findings in The Global Anti-Vascular Endothelial Growth Factor Therapeutic Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Aflibercept (Eylea)
Table 3. Major Manufacturers of Ranibizumab (Lucentis)
Table 4. Major Manufacturers of Brolucizumab (Beovu)
Table 5. Major Manufacturers of Others
Table 6. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Region (2018-2024)
Table 11. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Region (2024-2029)
Table 12. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region (2018-2024) & (K Units)
Table 14. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region (2024-2029) & (K Units)
Table 15. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Region (2018-2024)
Table 16. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Region (2024-2029)
Table 17. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Share by Manufacturers (2018-2024)
Table 19. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Anti-Vascular Endothelial Growth Factor Therapeutic, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Anti-Vascular Endothelial Growth Factor Therapeutic Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Anti-Vascular Endothelial Growth Factor Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Anti-Vascular Endothelial Growth Factor Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Vascular Endothelial Growth Factor Therapeutic as of 2022)
Table 25. Global Key Manufacturers of Anti-Vascular Endothelial Growth Factor Therapeutic, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Anti-Vascular Endothelial Growth Factor Therapeutic, Product Offered and Application
Table 27. Global Key Manufacturers of Anti-Vascular Endothelial Growth Factor Therapeutic, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2018-2024) & (K Units)
Table 30. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2024-2029) & (K Units)
Table 31. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Share by Type (2018-2024)
Table 32. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Share by Type (2024-2029)
Table 33. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Share by Type (2018-2024)
Table 36. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Share by Type (2024-2029)
Table 37. Anti-Vascular Endothelial Growth Factor Therapeutic Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Anti-Vascular Endothelial Growth Factor Therapeutic Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2018-2024) & (K Units)
Table 40. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2024-2029) & (K Units)
Table 41. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Share by Application (2018-2024)
Table 42. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Share by Application (2024-2029)
Table 43. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Share by Application (2018-2024)
Table 46. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Share by Application (2024-2029)
Table 47. Anti-Vascular Endothelial Growth Factor Therapeutic Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Anti-Vascular Endothelial Growth Factor Therapeutic Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2024-2029) & (K Units)
Table 62. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2018-2024) & (K Units)
Table 63. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2024-2029) & (K Units)
Table 64. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2018-2024) & (K Units)
Table 67. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2024-2029) & (K Units)
Table 68. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2018-2024) & (K Units)
Table 74. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2024-2029) & (K Units)
Table 75. China Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2018-2024) & (K Units)
Table 76. China Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2024-2029) & (K Units)
Table 77. China Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2018-2024) & (K Units)
Table 80. China Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2024-2029) & (K Units)
Table 81. China Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2018-2024) & (K Units)
Table 84. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2024-2029) & (K Units)
Table 85. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2018-2024) & (K Units)
Table 88. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2024-2029) & (K Units)
Table 89. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region (2018-2024) & (K Units)
Table 95. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2024-2029) & (K Units)
Table 109. Regeneron Pharmaceuticals Company Information
Table 110. Regeneron Pharmaceuticals Description and Major Businesses
Table 111. Regeneron Pharmaceuticals Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Regeneron Pharmaceuticals Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Regeneron Pharmaceuticals Recent Developments
Table 114. Bayer Company Information
Table 115. Bayer Description and Major Businesses
Table 116. Bayer Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Bayer Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Bayer Recent Developments
Table 119. Novartis Company Information
Table 120. Novartis Description and Major Businesses
Table 121. Novartis Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Novartis Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Novartis Recent Developments
Table 124. Roche Company Information
Table 125. Roche Description and Major Businesses
Table 126. Roche Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Roche Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Roche Recent Developments
Table 129. Biogen Company Information
Table 130. Biogen Description and Major Businesses
Table 131. Biogen Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Biogen Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Biogen Recent Developments
Table 134. Pfizer Company Information
Table 135. Pfizer Description and Major Businesses
Table 136. Pfizer Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Pfizer Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Pfizer Recent Developments
Table 139. Coherus BioSciences Company Information
Table 140. Coherus BioSciences Description and Major Businesses
Table 141. Coherus BioSciences Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Coherus BioSciences Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Coherus BioSciences Recent Developments
Table 144. Amgen Company Information
Table 145. Amgen Description and Major Businesses
Table 146. Amgen Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Amgen Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Amgen Recent Developments
Table 149. Bausch Health Companies Company Information
Table 150. Bausch Health Companies Description and Major Businesses
Table 151. Bausch Health Companies Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Bausch Health Companies Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Bausch Health Companies Recent Developments
Table 154. Viatris Company Information
Table 155. Viatris Description and Major Businesses
Table 156. Viatris Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Viatris Anti-Vascular Endothelial Growth Factor Therapeutic Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Viatris Recent Developments
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Anti-Vascular Endothelial Growth Factor Therapeutic Distributors List
Table 162. Anti-Vascular Endothelial Growth Factor Therapeutic Customers List
Table 163. Anti-Vascular Endothelial Growth Factor Therapeutic Market Trends
Table 164. Anti-Vascular Endothelial Growth Factor Therapeutic Market Drivers
Table 165. Anti-Vascular Endothelial Growth Factor Therapeutic Market Challenges
Table 166. Anti-Vascular Endothelial Growth Factor Therapeutic Market Restraints
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Vascular Endothelial Growth Factor Therapeutic Product Picture
Figure 2. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Share by Type in 2022 & 2029
Figure 4. Aflibercept (Eylea) Product Picture
Figure 5. Ranibizumab (Lucentis) Product Picture
Figure 6. Brolucizumab (Beovu) Product Picture
Figure 7. Others Product Picture
Figure 8. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Share by Application in 2022 & 2029
Figure 10. Macular Edema
Figure 11. Diabetic Retinopathy
Figure 12. Retinal Vein Occlusion
Figure 13. Age-related Macular Degeneration
Figure 14. Others
Figure 15. Anti-Vascular Endothelial Growth Factor Therapeutic Report Years Considered
Figure 16. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue 2018-2029 (US$ Million)
Figure 18. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 19. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Region (2018-2029)
Figure 20. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales 2018-2029 ((K Units)
Figure 21. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Region (2018-2029)
Figure 22. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Sales YoY (2018-2029) & (K Units)
Figure 23. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales YoY (2018-2029) & (K Units)
Figure 25. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue YoY (2018-2029) & (US$ Million)
Figure 26. China Anti-Vascular Endothelial Growth Factor Therapeutic Sales YoY (2018-2029) & (K Units)
Figure 27. China Anti-Vascular Endothelial Growth Factor Therapeutic Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Asia (excluding China) Anti-Vascular Endothelial Growth Factor Therapeutic Sales YoY (2018-2029) & (K Units)
Figure 29. Asia (excluding China) Anti-Vascular Endothelial Growth Factor Therapeutic Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales YoY (2018-2029) & (K Units)
Figure 31. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue YoY (2018-2029) & (US$ Million)
Figure 32. The Anti-Vascular Endothelial Growth Factor Therapeutic Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 33. The Top 5 and 10 Largest Manufacturers of Anti-Vascular Endothelial Growth Factor Therapeutic in the World: Market Share by Anti-Vascular Endothelial Growth Factor Therapeutic Revenue in 2022
Figure 34. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type (2018-2029)
Figure 36. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Type (2018-2029)
Figure 37. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Application (2018-2029)
Figure 38. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type (2018-2029)
Figure 40. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Type (2018-2029)
Figure 41. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Application (2018-2029)
Figure 42. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Application (2018-2029)
Figure 43. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Share by Country (2018-2029)
Figure 44. US & Canada Anti-Vascular Endothelial Growth Factor Therapeutic Sales Share by Country (2018-2029)
Figure 45. U.S. Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 46. Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 47. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type (2018-2029)
Figure 48. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Type (2018-2029)
Figure 49. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Application (2018-2029)
Figure 50. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Application (2018-2029)
Figure 51. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Share by Country (2018-2029)
Figure 52. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales Share by Country (2018-2029)
Figure 53. Germany Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 54. France Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 55. U.K. Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 56. Italy Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 57. Russia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 58. China Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type (2018-2029)
Figure 59. China Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Type (2018-2029)
Figure 60. China Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Application (2018-2029)
Figure 61. China Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Application (2018-2029)
Figure 62. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type (2018-2029)
Figure 63. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Type (2018-2029)
Figure 64. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Application (2018-2029)
Figure 65. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Application (2018-2029)
Figure 66. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Share by Region (2018-2029)
Figure 67. Asia Anti-Vascular Endothelial Growth Factor Therapeutic Sales Share by Region (2018-2029)
Figure 68. Japan Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 69. South Korea Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 70. China Taiwan Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 71. Southeast Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 72. India Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Share by Country (2018-2029)
Figure 78. Middle East, Africa and Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales Share by Country (2018-2029)
Figure 79. Brazil Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 80. Mexico Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 81. Turkey Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 82. Israel Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 83. GCC Countries Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (2018-2029) & (US$ Million)
Figure 84. Anti-Vascular Endothelial Growth Factor Therapeutic Value Chain
Figure 85. Anti-Vascular Endothelial Growth Factor Therapeutic Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed